05173nam 2200877Ia 450 991096999610332120251117115105.09786610176694978030916669003091666919781280176692128017669597803095281150309528119(CKB)111087027010022(OCoLC)60365106(CaPaEBR)ebrary10049167(SSID)ssj0000140161(PQKBManifestationID)12046533(PQKBTitleCode)TC0000140161(PQKBWorkID)10028420(PQKB)10093412(Au-PeEL)EBL3564024(CaPaEBR)ebr10049167(CaONFJC)MIL17669(OCoLC)54936876(MiAaPQ)EBC3564024(Perlego)4732427(BIP)10800483(EXLCZ)9911108702701002220040220d2004 uy 0engurcn|||||||||txtccrDistribution and administration of potassium iodide in the event of a nuclear incident /Committee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident, Board on Radiation Effects Research, Division of Earth and Life Studies, National Research Council of the National Academies1st ed.Washington, D.C. National Academies Press20041 online resource (262 p.)"Support by contract DHHS 200-2000-00629 task order no. 16, between the National Academy of Sciences and the Centers for Disease Control and Prevention"--T.p. verso.9780309090988 Print version: National Research Council (U.S.). Committee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Distribution and administration of potassium iodide in the event of a nuclear incident. Washington, D.C. : National Academies Press, 2004 0309090989 (DLC) 2003115709 (OCoLC)54457299 Includes bibliographical references.1.Introduction --2.Thyroid physiology --3.Potential exposure to radioactive iodine --4.Health consequences of radiation exposure --5.Protective measures --6.Existing distribution plans for potassium iodide --7.Process for evaluation of options for distribution of potassium iodide --8.Conclusions --App.A Public Law 107-188, Public Health Security and Bioterrorism Preparedness and Response Act of 2002, Conference Committee (05/21/02) --App. BFission product inventories --App. CPotassium iodide distribution in the States --App. DIllustration of process for evaluating KI distribution plans.Radioactive iodines are produced during the operation of nuclear power plants and during the detonation of nuclear weapons. In the event of a radiation incident, radioiodine is one of the contaminants that could be released into the environment. Exposure to radioiodine can lead to radiation injury to the thyroid, including thyroid cancer. Radiation to the thyroid from radioiodine can be limited by taking a nonradioactive iodine (stable iodine) such as potassium iodide. This book assesses strategies for the distribution and administration of potassium iodide (KI) in the event of a nuclear incident. The report says that potassium iodide pills should be available to everyone age 40 or younger "especially children and pregnant and lactating women "living near a nuclear power plant. States and municipalities should decide how to stockpile, distribute, and administer potassium iodide tablets, and federal agencies should keep a backup supply of tablets and be prepared to distribute them to affected areas.Thyroid glandCancerUntied StatesPreventionPotassium iodideTherapeutic useRadioactive falloutHealth aspectsEmergency managementRadiation-protective agentsRadiation-Protective Agentstherapeutic usePotassium IodideRadiation-Protective AgentsDisaster PlanningPotassium Iodideadministration & dosageUnited StatesThyroid glandCancerPrevention.Potassium iodideTherapeutic use.Radioactive falloutHealth aspects.Emergency management.Radiation-protective agents.Radiation-Protective Agentstherapeutic use.Potassium Iodide.Radiation-Protective Agents.Disaster Planning.Potassium Iodideadministration & dosage.362.196/9897025/0973National Research Council (U.S.).Board on Radiation Effects Research.MiAaPQMiAaPQMiAaPQBOOK9910969996103321Distribution and administration of potassium iodide in the event of a nuclear incident4346264UNINA